Cystitis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cystitis}} | {{Cystitis}} | ||
{{CMG}} {{AE}} {{USAMA}} | |||
==Overview== | ==Overview== | ||
Cystitis can be hard to treat and recurrence can be an important concern. The complications of cystitis and some carcinomas associated with it sometimes require an aggressive approach. new modalities help improve the existing treatment options and limit further complications.Pulsed | Cystitis can be hard to treat and recurrence can be an important concern. The complications of cystitis and some carcinomas associated with it sometimes require an aggressive approach. new modalities help improve the existing treatment options and limit further complications. Pulsed radiofrequency treatment is one such advancement.<ref name="pmid27930554">{{cite journal| author=Kim JH, Kim E, Kim BI| title=Pulsed radiofrequency treatment of the superior hypogastric plexus in an interstitial cystitis patient with chronic pain and symptoms refractory to oral and intravesical medications and bladder hydrodistension: A case report. | journal=Medicine (Baltimore) | year= 2016 | volume= 95 | issue= 49 | pages= e5549 | pmid=27930554 | doi=10.1097/MD.0000000000005549 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27930554 }} </ref> | ||
==Future Therapies== | ==Future Therapies== | ||
*Pulsed radiofrequency (PRF) treatment of the superior hypogastric plexus may replace conventional treatment invasive and on invasive modalities. It is responsible for providing superior hypogastric plexus with nondestructive modulation, so that majority of the pain signals are transferred from the pelvic viscera.<ref name="pmid27930554">{{cite journal| author=Kim JH, Kim E, Kim BI| title=Pulsed radiofrequency treatment of the superior hypogastric plexus in an interstitial cystitis patient with chronic pain and symptoms refractory to oral and intravesical medications and bladder hydrodistension: A case report. | journal=Medicine (Baltimore) | year= 2016 | volume= 95 | issue= 49 | pages= e5549 | pmid=27930554 | doi=10.1097/MD.0000000000005549 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27930554 }} </ref> | *Pulsed radiofrequency (PRF) treatment of the superior [[hypogastric plexus]] may replace conventional treatment invasive and on invasive modalities. It is responsible for providing superior [[hypogastric plexus]] with nondestructive modulation, so that majority of the pain signals are transferred from the pelvic viscera.<ref name="pmid27930554">{{cite journal| author=Kim JH, Kim E, Kim BI| title=Pulsed radiofrequency treatment of the superior hypogastric plexus in an interstitial cystitis patient with chronic pain and symptoms refractory to oral and intravesical medications and bladder hydrodistension: A case report. | journal=Medicine (Baltimore) | year= 2016 | volume= 95 | issue= 49 | pages= e5549 | pmid=27930554 | doi=10.1097/MD.0000000000005549 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27930554 }} </ref> | ||
*Various approaches are being tried to prevent the developing resistance to certain medications. These include:<ref name="pmid16413668">{{cite journal| author=Wagenlehner FM, Naber KG| title=Treatment of bacterial urinary tract infections: presence and future. | journal=Eur Urol | year= 2006 | volume= 49 | issue= 2 | pages= 235-44 | pmid=16413668 | doi=10.1016/j.eururo.2005.12.017 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16413668 }} </ref> | |||
* | **Avoid prolonged use of broad spectrum [[antibiotics]] | ||
**Optimal dosing | |||
* | **Preventing [[infection]] | ||
**Developing new agents | |||
==References== | ==References== | ||
| Line 17: | Line 18: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Nephrology]] | |||
[[Category:Urology]] | |||
Latest revision as of 21:12, 29 July 2020
|
Cystitis Microchapters | |
|
Diagnosis | |
|
Treatment | |
|
Case Studies | |
|
Cystitis future or investigational therapies On the Web | |
|
American Roentgen Ray Society Images of Cystitis future or investigational therapies | |
|
Risk calculators and risk factors for Cystitis future or investigational therapies | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Cystitis can be hard to treat and recurrence can be an important concern. The complications of cystitis and some carcinomas associated with it sometimes require an aggressive approach. new modalities help improve the existing treatment options and limit further complications. Pulsed radiofrequency treatment is one such advancement.[1]
Future Therapies
- Pulsed radiofrequency (PRF) treatment of the superior hypogastric plexus may replace conventional treatment invasive and on invasive modalities. It is responsible for providing superior hypogastric plexus with nondestructive modulation, so that majority of the pain signals are transferred from the pelvic viscera.[1]
- Various approaches are being tried to prevent the developing resistance to certain medications. These include:[2]
- Avoid prolonged use of broad spectrum antibiotics
- Optimal dosing
- Preventing infection
- Developing new agents
References
- ↑ 1.0 1.1 Kim JH, Kim E, Kim BI (2016). "Pulsed radiofrequency treatment of the superior hypogastric plexus in an interstitial cystitis patient with chronic pain and symptoms refractory to oral and intravesical medications and bladder hydrodistension: A case report". Medicine (Baltimore). 95 (49): e5549. doi:10.1097/MD.0000000000005549. PMID 27930554.
- ↑ Wagenlehner FM, Naber KG (2006). "Treatment of bacterial urinary tract infections: presence and future". Eur Urol. 49 (2): 235–44. doi:10.1016/j.eururo.2005.12.017. PMID 16413668.